Article

Cole named Transitions president

Dave Cole has been appointed as president of Transitions Optical, Inc., effective immediately. Cole, who had been serving as the company?s chief operating officer since October 2010, will assume full responsibility for the Transitions Optical business.

Pinellas Park, FL-Dave Cole has been appointed as president of Transitions Optical Inc. effective immediately.

Cole, who had been serving as the company’s chief operating officer since October 2010, will assume full responsibility for the Transitions Optical business.

Cole has been with Transitions Optical in various roles since the company was launched in 1990. As president, he will be accountable for effectively leveraging the regional and global leadership teams, and business strategy development and execution, while continuing to build strong strategic partnerships to drive the overall photochromic market.

“In the time Dave served as chief operating officer, he showed again and again how exceptionally well suited he is to lead Transitions Optical globally,” said Rick Elias, chief executive officer, Transitions Optical. “His in-depth knowledge of the optical industry and our business, ability to act continuously with long-term perspective, and capability for building strong relationships within the industry and internally are just a few of his notable strengths.”

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
At the 2025 ASCRS Annual Meeting, Weijie Violet Lin, MD, ABO, shares highlights from a 5-year review of cross-linking complications
Maanasa Indaram, MD, is the medical director of the pediatric ophthalmology and adult strabismus division at University of California San Francisco, and spoke about corneal crosslinking (CXL) at the 2025 ASCRS annual meeting
(Image credit: Ophthalmology Times) ASCRS 2025: Taylor Strange, DO, assesses early visual outcomes with femto-created arcuate incisions in premium IOL cases
(Image credit: Ophthalmology Times) ASCRS 2025: Neda Shamie, MD, shares her early clinical experience with the Unity VCS system
Patricia Buehler, MD, MPH, founder and CEO of Osheru, talks about the Ziplyft device for noninvasive blepharoplasty at the 2025 American Society of Cataract and Refractive Surgeons (ASCRS) annual meeting
(Image credit: Ophthalmology Times) ASCRS 2025: Bonnie An Henderson, MD, on leveraging artificial intelligence in cataract refractive surgery
(Image credit: Ophthalmology Times) ASCRS 2025: Gregory Moloney, FRANZO, FRCSC, on rotational stability
Sheng Lim, MD, FRCOphth, discusses the CONCEPT study, which compared standalone cataract surgery to cataract surgery with ECP, at the 2025 ASCRS Annual Meeting.
(Image credit: Ophthalmology Times) ASCRS 2025: Steven J. Dell, MD, reports 24-month outcomes for shape-changing IOL
Alex Hacopian, MD, discusses a presbyopia-correcting IOL at the 2025 American Society of Cataract and Refractive Surgeons (ASCRS) annual meeting
© 2025 MJH Life Sciences

All rights reserved.